CVS Health Announces Plan To Split Into Two Publicly Traded Companies By 2028

CVS Health has announced plans to split into two independent, publicly traded companies: a healthcare solutions business focused on insurance, pharmacy benefits, specialty pharmacy, and care delivery, and a national retail pharmacy and community healthcare company. The company expects to complete the separation in the first half of 2028.

The decision follows a comprehensive strategic review by CVS Health’s Board of Directors and is intended to provide each business with greater operational focus, financial flexibility, and opportunities for growth.

The healthcare solutions company, which will retain the CVS Health name, will include Aetna, CVS Caremark, CVS Specialty, Oak Street Health, and Signify Health. The business will focus on integrating health benefits, pharmacy services, primary care, and home-based healthcare to improve patient outcomes and manage costs.

The second company, CVS Pharmacy, will operate approximately 9,000 retail pharmacy locations, mail pharmacy services, MinuteClinic facilities and virtual care offerings, and the Health100 technology services business.

CVS Pharmacy will continue to serve communities through its nationwide network of nearly 30,000 pharmacists while expanding relationships with health insurers, pharmacy benefit managers, manufacturers, and other healthcare organizations.

The two businesses will have separate leadership teams and capital structures, allowing them to pursue investments and operational strategies tailored to their respective markets.

Upon completion of the separation, David Joyner, currently Chairman and CEO of CVS Health, will become Chairman and CEO of the healthcare solutions company.

Prem Shah, currently Group President of CVS Health, will become CEO of CVS Pharmacy. Additional executive appointments and board memberships will be announced as the separation progresses.

Both companies plan to invest in technology designed to make healthcare more accessible and easier to navigate. Health100, an AI-native technology platform, will remain an important component of their respective strategies.

CVS Health expects both companies to maintain solid investment-grade credit ratings, generate strong free cash flow, and have the financial capacity to pursue strategic investments and pay dividends.

The separation is intended to qualify as tax-free to CVS Health and its shareholders for U.S. federal income tax purposes. Existing shareholders are expected to own shares in both companies following completion.

The transaction remains subject to final board approval, regulatory and filing requirements, and confirmation of its intended tax treatment.

Until the separation is completed, CVS Health will continue operating its businesses under the existing organizational structure, with no anticipated interruption to customer benefits, pharmacy services, or patient care.

As of September 30, 2026, CVS Health operated approximately 9,000 pharmacies and more than 1,000 walk-in and primary care clinics. Its pharmacy benefits business served approximately 87 million plan members, while its health insurance and related services reached an estimated 37 million people.

The company also announced its third-quarter 2026 results and increased its full-year financial guidance in a separate release.

Goldman Sachs is serving as lead financial and strategic advisor, with Consello providing additional financial and strategic advice. Wachtell, Lipton, Rosen & Katz is serving as legal counsel.

KEY QUOTES:

“Our history is defined by proactively evolving to stay ahead of what’s next in healthcare, and in today’s environment, that means delivering more affordability, greater access, and a simpler experience. Over the last two years, we have made meaningful progress: we built a world-class leadership team, strengthened our financials, revitalized operations across the enterprise, and drove total shareholder return. From a position of strength, and a focus on the long term, we plan to create two focused companies to improve consumer engagement, affordability, and care coordination. Aetna, CVS Caremark and CVS Specialty, along with our value-based care and in-home health businesses, will advance together as a leading healthcare solutions provider, delivering differentiated, comprehensive benefits to clients, members and patients. CVS Pharmacy will build on its position as America’s leading retail pharmacy, serving as the front door to health and care in our country as the most frequently accessed consumer health touchpoint. Both companies will continue to advance innovative technology solutions to improve the healthcare experience as we deliver on our purpose to simplify healthcare, one person, one family and one community at a time.”

David Joyner, Chairman And CEO Of CVS Health